4.6 Article

MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma

Related references

Note: Only part of the references are listed.
Article Cell Biology

The Promoter Hypermethylation Status of GATA6, MGMT, and FHIT in Glioblastoma

Gulsah Cecener et al.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2012)

Article Clinical Neurology

A clinicopathological and molecular analysis of glioblastoma multiforme with long-term survival

Prasenjit Das et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2011)

Article Biotechnology & Applied Microbiology

DNA methylation in glioblastoma: impact on gene expression and clinical outcome

Amandine Etcheverry et al.

BMC GENOMICS (2010)

Article Biochemistry & Molecular Biology

A microarray-based DNA methylation study of glioblastoma multiforme

Ramon Martinez et al.

EPIGENETICS (2009)

Article Surgery

Lack of death receptor 4 (DR4) expression through gene promoter methylation in gastric carcinoma

Kyung Hwa Lee et al.

LANGENBECKS ARCHIVES OF SURGERY (2009)

Article Gastroenterology & Hepatology

Transcription factors GATA-4 and GATA-6 in normal and neoplastic human gastrointestinal mucosa

Hanna Haveri et al.

BMC GASTROENTEROLOGY (2008)

Article Multidisciplinary Sciences

GATA6 is an astrocytoma tumor suppressor gene identified by gene trapping of mouse glioma model

Deepak Kamnasaran et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Biochemistry & Molecular Biology

Histone modifications silence the GATA transcription factor genes in ovarian cancer

C. Caslini et al.

ONCOGENE (2006)

Article Medicine, General & Internal

MGMT gene silencing and benefit from temozolomide in glioblastoma

ME Hegi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Oncology

Hypermethylation of the GATA genes in lung cancer

MZ Guo et al.

CLINICAL CANCER RESEARCH (2004)